Literature DB >> 194841

Protection against herpes simplex virus infection in mice by Corynebacterium parvum.

H Kirchner, H M Hirt, K Munk.   

Abstract

Corynebacterium parvum administered in mice prior to herpes simplex virus (HSV) infection significantly protected them against lethal encephalitis. This was seen both with a mouse strain highly susceptible to HSV and with one relatively resistant to HSV. Mice immunosuppressed by cyclophosphamide and showing an increased mortality after HSV infection were also protected by C. parvum pretreatment. However, C. parvum given simultaneously with or after HSV infection did not exert a therapeutic effect.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 194841      PMCID： PMC421479          DOI： 10.1128/iai.16.1.9-11.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  11 in total

1.  Pathogenesis of recurrent herpes simplex infections.

Authors:  C E Wheeler
Journal:  J Invest Dermatol       Date:  1975-10       Impact factor: 8.551

2.  [CYTOPATHIC EFFECT AND PLAQUE MORPHOLOGY OF VARIOUS HERPES SIMPLEX VIRUS STRAINS].

Authors:  K MUNK; D DONNER
Journal:  Arch Gesamte Virusforsch       Date:  1963-08-26

3.  Genetics of natural resistance to herpesvirus infections in mice.

Authors:  C Lopez
Journal:  Nature       Date:  1975-11-13       Impact factor: 49.962

4.  Effects of immunostimulants on resistance of newborn mice to herpes simplex type 2 infection.

Authors:  S E Starr; A M Visintine; M O Tomeh; A J Nahmias
Journal:  Proc Soc Exp Biol Med       Date:  1976-05

Review 5.  Question: do herpesviruses cause cancer? Answer: of course they do.

Authors:  F Rapp
Journal:  J Natl Cancer Inst       Date:  1973-04       Impact factor: 13.506

6.  Selective effects of anti-macrophage serum, silica and anti-lymphocyte serum on pathogenesis of herpes virus infection of young adult mice.

Authors:  B Zisman; M S Hirsch; A C Allison
Journal:  J Immunol       Date:  1970-05       Impact factor: 5.422

7.  [Corynebacterium parvum in advanced cancers. 1st evaluation of the therapeutic activity of this immunostimulin].

Authors:  L Israël; B Halpern
Journal:  Nouv Presse Med       Date:  1972-01-01

Review 8.  On the role of mononuclear phagocytes in immunity against viruses.

Authors:  A C Allison
Journal:  Prog Med Virol       Date:  1974

9.  Herpes simplex vaccines.

Authors:  M R Hilleman
Journal:  Cancer Res       Date:  1976-02       Impact factor: 12.701

Review 10.  Corynebacterium parvum as an immunotherapeutic anticancer agent.

Authors:  M T Scott
Journal:  Semin Oncol       Date:  1974-12       Impact factor: 4.929
View more
  14 in total

1.  The mechanism of poly I:C-induced antiviral activity in peritoneal macrophage.

Authors:  S Pyo
Journal:  Arch Pharm Res       Date:  1994-04       Impact factor: 4.946

2.  Enhanced resistance against encephalomyocarditis virus infection in mice, induced by a nonviable Mycobacterium tuberculosis oil-droplet vaccine.

Authors:  D L Lodmell; L C Ewalt
Journal:  Infect Immun       Date:  1978-01       Impact factor: 3.441

3.  Enhanced resistance against Junin virus infection induced by Corynebacterium parvum.

Authors:  D B Budzko; J Casals; B H Waksman
Journal:  Infect Immun       Date:  1978-03       Impact factor: 3.441

4.  Protection of mice against mouse hepatitis virus by Corynebacterium parvum.

Authors:  L Schindler; G Streissle; H Kirchner
Journal:  Infect Immun       Date:  1981-06       Impact factor: 3.441

5.  Interferon production and lymphocyte stimulation in human leucocyte cultures stimulated by Corynebacterium parvum.

Authors:  H M Hirt; M Schwenteck; H Becker; H Kirchner
Journal:  Clin Exp Immunol       Date:  1978-06       Impact factor: 4.330

6.  Colonization of adrenal glands and ovaries of mice by HSV-2 variants. I. Virological studies.

Authors:  J Podlech; K Weise; D Falke
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

Review 7.  Pathogenesis of malaria and clinically similar conditions.

Authors:  Ian A Clark; Lisa M Alleva; Alison C Mills; William B Cowden
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

8.  Early interactions of herpes simplex virus with mouse peritoneal macrophages.

Authors:  B Svennerholm; A Vahlne; E Lycke
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

9.  Macrophage dependence of polyriboinosinic acid-polyribocytidylic acid-induced resistance to herpes simplex virus infection in mice.

Authors:  D Martinez; R J Lynch; J B Meeker; A K Field
Journal:  Infect Immun       Date:  1980-04       Impact factor: 3.441

10.  Enhancement of natural resistance to influenza virus in lipopolysaccharide-responsive and -nonresponsive mice by Propionibacterium acnes.

Authors:  J D Gangemi; J A Hightower; R A Jackson; M H Maher; M G Welsh; M M Sigel
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.